PHILADELPHIA, May 12, 2011 /PRNewswire/ -- The University of the Sciences Board of Trustees
A world-renowned leader in injectable manufacturing and delivery systems, Samson has served on the University's board in numerous capacities since 1991, including vice chair since 2000. He is founder and chief executive officer of Samson Medical Technologies, LLC, a company specializing in injectable drug delivery systems and programs for hospital and alternate site pharmacists.
A native of Philadelphia, Samson received his BS in chemistry from Temple University. In 2007, he joined Qualitest Pharmaceuticals, Inc. as chairman of the board and chief executive officer, where he remained until the purchase of Qualitest by Endo Pharmaceuticals at the end of 2010. He is currently serving as a consultant to Endo Pharmaceuticals. In addition, Samson is a member of the board of directors of Baxa Corporation, Flynn Pharma, Emcure Pharmaceuticals Limited, and Dobfar Holdings S.p.A. Over the years, his gifts to USciences have supported the Marvin Samson Center for the History of Pharmacy Museum and the Misher Visiting Professorship in the Humanities. In addition, he chaired the University's most recent capital campaign. In recognition for his commitment to the University's mission, the Samson College of Health Sciences was named after him in November 2009.
Howard's business career includes 12 years in commercial banking and 19 years in healthcare management. Howard served on the USciences board of trustees from 1995 to 2004 and rejoined the board in 2007, where he has been a member of the Finance and Audit Committee and Executive Committee. Since 2009, Howard has served as CEO and investor at Advanced Pharmacy Services, Inc., in Houston, Texas. A private equity financed institutional pharmacy services company, Advanced Pharmacy Services provides prescription medications to skilled nursing centers. A graduate of the Wharton School at the University of Pennsylvania in 1971 with a degree in corporate finance, Howard began his career at Fidelity Bank where he was a vice president. He went on to tenures at Health Group Care Centers, Inc., Equibank, Genesis Health Ventures, Inc., and Flagship Global Health, Inc.
Payne announced on April 29 that he would retire from the board in May 2011. The University's 190th Commencement on May 25 will be his last official act. Payne has served on the USciences board since 1990 and as chair since 2000. In honor of his dedication, the board elected Payne an emeritus trustee.
At University of the Sciences, students embark on a challenging learning experience in a proving ground for successful professionals in the science and healthcare-related fields. A private institution dedicated to education, research, and service, and distinguished as the nation's first college of pharmacy, the University has produced leaders in the science and healthcare marketplaces since its founding in 1821. Students in USciences' five colleges learn to excel in scientific analysis and to apply their skills to improving healthcare in the lives of people worldwide through such disciplines as pharmacy, biology, physical therapy, healthcare business, and health policy. For more information, visit usciences.edu.
SOURCE University of the Sciences
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All